Medicskin Holdings Limited, an investment holding company, provides medical skin care services primarily in Hong Kong.
Price History & Performance
|Historical stock prices|
|Current Share Price||HK$0.28|
|52 Week High||HK$0.10|
|52 Week Low||HK$0.38|
|1 Month Change||32.07%|
|3 Month Change||-3.45%|
|1 Year Change||60.00%|
|3 Year Change||-1.75%|
|5 Year Change||-73.08%|
|Change since IPO||-91.03%|
Recent News & Updates
Shareholders Will Probably Hold Off On Increasing Medicskin Holdings Limited's (HKG:8307) CEO Compensation For The Time Being
In the past three years, shareholders of Medicskin Holdings Limited ( HKG:8307 ) have seen a loss on their investment...
|8307||HK Healthcare||HK Market|
Return vs Industry: 8307 exceeded the Hong Kong Healthcare industry which returned -44.4% over the past year.
Return vs Market: 8307 exceeded the Hong Kong Market which returned 5.7% over the past year.
Stable Share Price: 8307 is more volatile than 90% of Hong Kong stocks over the past 3 months, typically moving +/- 18% a week.
Volatility Over Time: 8307's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
|2000||39||Kwok Leung Kong||https://www.medicskin.com|
Medicskin Holdings Limited, an investment holding company, provides medical skin care services primarily in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems, such as acne, pigmentation, rosacea, dermatitis, eczema, and warts, as well as improvement of appearance through alia, skin rejuvenation, facial sculpturing, and body contouring treatments; and treatment of acne scars and enlarged pores, removal of undesirable naevi, and hair removal, as well as lasers and light sources treatment, ultrasound treatment, and radio-frequency treatment. It is also involved in the sale of skincare products; provision of skin care and health management services; and property holding activities.
Medicskin Holdings Fundamentals Summary
|8307 fundamental statistics|
Is 8307 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|8307 income statement (TTM)|
|Cost of Revenue||HK$28.04m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Nov 11, 2021
|Earnings per share (EPS)||0.004|
|Net Profit Margin||3.53%|
How did 8307 perform over the long term?See historical performance and comparison
Is Medicskin Holdings undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 8307 (HK$0.28) is trading below our estimate of fair value (HK$0.63)
Significantly Below Fair Value: 8307 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 8307 is poor value based on its PE Ratio (70x) compared to the Hong Kong Healthcare industry average (16.5x).
PE vs Market: 8307 is poor value based on its PE Ratio (70x) compared to the Hong Kong market (9.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 8307's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 8307 is overvalued based on its PB Ratio (4.7x) compared to the HK Healthcare industry average (1.7x).
How is Medicskin Holdings forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medicskin Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Medicskin Holdings performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 8307 has a large one-off gain of HK$1.8M impacting its June 30 2021 financial results.
Growing Profit Margin: 8307 became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: 8307's earnings have declined by 36.7% per year over the past 5 years.
Accelerating Growth: 8307 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 8307 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (29.5%).
Return on Equity
High ROE: 8307's Return on Equity (9.5%) is considered low.
How is Medicskin Holdings's financial position?
Financial Position Analysis
Short Term Liabilities: 8307's short term assets (HK$45.9M) exceed its short term liabilities (HK$38.2M).
Long Term Liabilities: 8307's short term assets (HK$45.9M) exceed its long term liabilities (HK$661.0K).
Debt to Equity History and Analysis
Debt Level: 8307's debt to equity ratio (32.1%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 8307's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 8307's debt is well covered by operating cash flow (142.5%).
Interest Coverage: Insufficient data to determine if 8307's interest payments on its debt are well covered by EBIT.
What is Medicskin Holdings's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 8307's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 8307's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 8307's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 8307's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: 8307 is not paying a notable dividend for the Hong Kong market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 8307's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Kwok Leung Kong (67 yo)
Dr. Kwok Leung Kong serves as Chief Executive officer of Medicskin Holdings Ltd (“Company”) since March 01, 2018 and serves as its Founder and Chairman of the Board. Dr. Kong graduated from the Faculty of...
CEO Compensation Analysis
Compensation vs Market: Kwok Leung's total compensation ($USD609.31K) is above average for companies of similar size in the Hong Kong market ($USD228.05K).
Compensation vs Earnings: Kwok Leung's compensation has been consistent with company performance over the past year.
Experienced Management: 8307's management team is seasoned and experienced (7.6 years average tenure).
Experienced Board: 8307's board of directors are considered experienced (6.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Medicskin Holdings Limited's employee growth, exchange listings and data sources
- Name: Medicskin Holdings Limited
- Ticker: 8307
- Exchange: SEHK
- Founded: 2000
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: HK$111.086m
- Shares outstanding: 396.74m
- Website: https://www.medicskin.com
Number of Employees
- Medicskin Holdings Limited
- Champion Building
- 16th Floor
- Hong Kong
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/22 15:49|
|End of Day Share Price||2021/10/22 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.